pSLQ1651-sgRNA(F+E)-sgGal4 Citations (7)
Originally described in: In Situ Capture of Chromatin Interactions by Biotinylated dCas9.Liu X, Zhang Y, Chen Y, Li M, Zhou F, Li K, Cao H, Ni M, Liu Y, Gu Z, Dickerson KE, Xie S, Hon GC, Xuan Z, Zhang MQ, Shao Z, Xu J Cell. 2017 Aug 24;170(5):1028-1043.e19. doi: 10.1016/j.cell.2017.08.003. PubMed Journal
Articles Citing pSLQ1651-sgRNA(F+E)-sgGal4
| Articles |
|---|
| CAPTURE: In Situ Analysis of Chromatin Composition of Endogenous Genomic Loci by Biotinylated dCas9. Liu X, Zhang Y, Chen Y, Li M, Shao Z, Zhang MQ, Xu J. Curr Protoc Mol Biol. 2018 Jul;123(1):e64. doi: 10.1002/cpmb.64. Epub 2018 Jun 19. PubMed |
Multiplexed capture of spatial configuration and temporal dynamics of locus-specific 3D chromatin by biotinylated dCas9.
Liu X, Chen Y, Zhang Y, Liu Y, Liu N, Botten GA, Cao H, Orkin SH, Zhang MQ, Xu J.
Genome Biol. 2020 Mar 5;21(1):59. doi: 10.1186/s13059-020-01973-w.
PubMed
Associated Plasmids |
| SIRT1 regulates sphingolipid metabolism and neural differentiation of mouse embryonic stem cells through c-Myc-SMPDL3B. Fan W, Tang S, Fan X, Fang Y, Xu X, Li L, Xu J, Li JL, Wang Z, Li X. Elife. 2021 May 27;10. pii: 67452. doi: 10.7554/eLife.67452. PubMed |
| Inner nuclear protein Matrin-3 coordinates cell differentiation by stabilizing chromatin architecture. Cha HJ, Uyan O, Kai Y, Liu T, Zhu Q, Tothova Z, Botten GA, Xu J, Yuan GC, Dekker J, Orkin SH. Nat Commun. 2021 Oct 29;12(1):6241. doi: 10.1038/s41467-021-26574-4. PubMed |
| HOXB13 suppresses de novo lipogenesis through HDAC3-mediated epigenetic reprogramming in prostate cancer. Lu X, Fong KW, Gritsina G, Wang F, Baca SC, Brea LT, Berchuck JE, Spisak S, Ross J, Morrissey C, Corey E, Chandel NS, Catalona WJ, Yang X, Freedman ML, Zhao JC, Yu J. Nat Genet. 2022 May;54(5):670-683. doi: 10.1038/s41588-022-01045-8. Epub 2022 Apr 25. PubMed |
| The risk variant rs11836367 contributes to breast cancer onset and metastasis by attenuating Wnt signaling via regulating NTN4 expression. Yang H, Ting X, Geng YH, Xie Y, Nierenberg JL, Huo YF, Zhou YT, Huang Y, Yu YQ, Yu XY, Li XF, Ziv E, Zhang H, Fang WG, Shen Y, Tian XX. Sci Adv. 2022 Jun 10;8(23):eabn3509. doi: 10.1126/sciadv.abn3509. Epub 2022 Jun 10. PubMed |
| Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance. Lyu J, Liu Y, Gong L, Chen M, Madanat YF, Zhang Y, Cai F, Gu Z, Cao H, Kaphle P, Kim YJ, Kalkan FN, Stephens H, Dickerson KE, Ni M, Chen W, Patel P, Mims AS, Borate U, Burd A, Cai SF, Yin CC, You MJ, Chung SS, Collins RH, DeBerardinis RJ, Liu X, Xu J. Cancer Discov. 2023 Jan 9;13(1):170-193. doi: 10.1158/2159-8290.CD-21-1661. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.